Accès gratuit
| Numéro |
Radioprotection
Volume 55, Numéro 3, July-September 2020
|
|
|---|---|---|
| Page(s) | 165 - 172 | |
| DOI | https://doi.org/10.1051/radiopro/2020050 | |
| Publié en ligne | 20 mai 2020 | |
- Abbas E. 2018. Surgical management of lung cancer: history, evolution, and modern advances. Curr. Oncol. Rep. 20(12): 98. [CrossRef] [PubMed] [Google Scholar]
- Ball D, et al. 2019. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 20(4): 494–503. [CrossRef] [PubMed] [Google Scholar]
- Bourguignon M, Bérard P, Bertho J, Farah J, Mercat C. 2017. What’s next in radioprotection? Radioprotection 52: 21–28. [CrossRef] [EDP Sciences] [Google Scholar]
- Chan C, et al. 2014. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J. Thorac. Oncol. 9(11): 1598–1608. [Google Scholar]
- Chun SG, et al. 2015. Comparison of 3-D conformal and intensity modulated radiation therapy outcomes for locally advanced non-small cell lung cancer in NRG oncology/RTOG 0617. Int. J. Radiat. Oncol. Biol. Phys. 93(3): S1–S2. [Google Scholar]
- Cosset JM, et al. 2013. Hypofractionnement en radiothérapie : l’éternel retour. Cancer Radiother. 17(5–6): 355–362. [CrossRef] [PubMed] [Google Scholar]
- Coutard H. 1934. Principles of X-ray therapy of malignant diseases. Lancet 2: 1–12. [Google Scholar]
- Despeignes V. 1896. Observation concernant un cas de cancer de l’estomac traité par les rayons Rontgen. Lyon Med. 82: 428. [Google Scholar]
- Dieterich S, et al. 2018. SBRT targets that move with respiration. Phys. Med. 56: 19–24. [CrossRef] [PubMed] [Google Scholar]
- Durdux C, et al. 2018. Principes et techniques de la radiothérapie thoracique des carcinomes bronchiques non à petites cellules (CBNPC). Rev. Mal. Respir. Actual. 10(3): 303–313. [Google Scholar]
- Foray N. 2016a. Les origines lyonnaises de la radiothérapie anticancéreuse. Dans : Conférence université de Lyon, 25 mai 2016. https://popsciences.universite-lyon.fr/. [Google Scholar]
- Foray N. 2016b. Victor Despeignes, the forgotten pioneer of radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 96(4): 717–721. [CrossRef] [PubMed] [Google Scholar]
- Franks KN, et al. 2015. Stereotactic ablative body radiotherapy for lung cancer. Clin. Oncol. 27(5): 280–289. [CrossRef] [PubMed] [Google Scholar]
- Hamaji M. 2019. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future. Gen. Thorac. Cardiovasc. Surg. Special Edition. [Google Scholar]
- Hamaji M, et al. 2019. Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses. J. Thorac. Dis. 11(Suppl. 13): S1646–S1652. [CrossRef] [PubMed] [Google Scholar]
- Horn L, Johnson DH. 2008. Evarts A. Graham and the first pneumonectomy for lung cancer. J. Clin. Oncol. 26(19): 3268–3275. [CrossRef] [PubMed] [Google Scholar]
- Khaitan PG, D’Amico TA. 2018. Milestones in thoracic surgery. J. Thorac. Cardiovasc. Surg. 155(6): 2779–2789. [CrossRef] [PubMed] [Google Scholar]
- Koshy M, et al. 2017. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy. Lung Cancer 108: 222–227. [CrossRef] [PubMed] [Google Scholar]
- Koshy M, et al. 2015. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 91(2): 344–350. [CrossRef] [PubMed] [Google Scholar]
- Lanni TB, et al. 2011. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am. J. Clin. Oncol. Cancer Clin. Trials 34(5): 494–498. [Google Scholar]
- Lefebvre L, et al. 2014. New techniques and potential benefits for radiotherapy of lung cancer. Cancer Radiother. 18(5–6): 473–479. [CrossRef] [PubMed] [Google Scholar]
- Liao ZX, et al. 2010. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 76(3): 775–781. [CrossRef] [PubMed] [Google Scholar]
- Menoux I, et al. 2018. Radiation-induced lung toxicity predictors after stereotactic radiation therapy for non-small cell lung carcinoma stage I. Cancer Radiother. 22(8): 826–838. [CrossRef] [PubMed] [Google Scholar]
- Menten MJ, et al. 2017. MRI-guided lung SBRT: present and future developments. Phys. Med. 44: 139–139. [CrossRef] [PubMed] [Google Scholar]
- Modlin IM, et al. 2014. A historical appreciation of bronchopulmonary neuroendocrine neoplasia. Thorac. Surg. Clin. 24(3): 235–255. [CrossRef] [PubMed] [Google Scholar]
- De Neve W, et al. 1999. Modulation d’intensité en radiothérapie par collimateur multi-lame dynamique. Technique et expérience clinique. Cancer Radiother. 3(5): 378–392. [CrossRef] [PubMed] [Google Scholar]
- Nyman J, et al. 2016. SPACE − A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother. Oncol. 121(1): 1–8. [PubMed] [Google Scholar]
- Ochsner A. 1978. The development of pulmonary surgery, with special emphasis on carcinoma and bronchiectasis. Am. J. Surg. 135(6): 732–746. [CrossRef] [PubMed] [Google Scholar]
- Regaud C, Blanc J. 1906. Action des rayons X sur les diverses générations de la lignée spermatique. Extrême sensibilité des spermatogonies à ces rayons. C. R. Soc. Biol. (202): 892. [Google Scholar]
- Shimkin MB, et al. 1962. Pneumonectomy and lobectomy in bronchogenic carcinoma. a comparison of end results of the Overholt and Ochsner clinics. J. Thorac. Cardiovasc. Surg. 44: 503–519. [CrossRef] [PubMed] [Google Scholar]
- Shiu AS, et al. 2003. Near simultaneous computed tomography stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int. J. Radiat. Oncol. Biol. Phys. 57: 605–613. [CrossRef] [PubMed] [Google Scholar]
- Solberg JL, et al. 2012. Historical development of stereotactic ablative radiotherapy. Radiat. Oncol. 39(1): 191–197. [Google Scholar]
- Videtic GM, et al. 2019. Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 103(5): 1077–1084. [CrossRef] [PubMed] [Google Scholar]
- Widder J, et al. 2011. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 81(4): 291–297. [Google Scholar]
- Yaprak G, et al. 2019. Is stereotactic body radiotherapy an alternative to surgery in early stage non small cell lung cancer? J. BUON 24(4): 1619–1625. [PubMed] [Google Scholar]
- Yenice KM, et al. 2003. CT image-guided intensity modulated therapy for paraspinal tumors using stereotactic immobilization. Int. J. Radiat. Oncol. Biol. Phys. 55: 583–593. [CrossRef] [PubMed] [Google Scholar]
- Yom SS, et al. 2007. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 68(1): 94–102. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.